Urinary Tract Infection: Beyond Uncomplicated Cystitis

  • Christopher K. PayneEmail author
  • Jeannette M. Potts
Part of the Current Clinical Urology book series (CCU)


Various types of urinary tract infections (UTIs) affecting specific patient populations are addressed in several other chapters of this book, within the context of a respective theme. This chapter addresses UTI in general, with an expanded focus on recurrent infections in women and complicated infections in patients with neurological disorders, those who require urinary catheterization or who are in an immunocompromised state. Sexually transmitted infections of the urethra and vagina are also discussed. The intent of the authors is to raise awareness regarding types of infections occurring in diverse patient populations and to enhance evaluation the evaluation skills of health-care providers by broadening the differential diagnosis. Judicious use of antibiotics is emphasized to avoid antibiotic overuse, a current serious public health concern.


Sexually Transmit Infection Urine Culture Neurogenic Bladder Clean Intermittent Catheterization Nucleic Acid Amplification Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Centers for Disease Control and Prevention. 2005. Accessed 17 Feb 2012.
  2. 2.
    Griebling TL. Urinary tract infection in women. In: Litwin MS, Saigal CS, editors. Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington: US Government Publishing Office; 2007. p. 587–620. NIH Publication No. 07-5512.Google Scholar
  3. 3.
    Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509–15.PubMedCrossRefGoogle Scholar
  4. 4.
    Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80(3):331.PubMedCrossRefGoogle Scholar
  5. 5.
    Litwin MS, Saigal CS. Introduction. In: Litwin MS, Saigal CS, editors. Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington: US Government Publishing Office; 2007. p. 5. NIH Publication No. 07-5512Google Scholar
  6. 6.
    Epp A, Larochelle A, Lovatsis D, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can. 2010;32(11):1082–101.PubMedGoogle Scholar
  7. 7.
    American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111(3):785–94.CrossRefGoogle Scholar
  8. 8.
    Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Hunstad DA, Justice SS. Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol. 2010;64:203–21.PubMedCrossRefGoogle Scholar
  10. 10.
    Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection. Nat Rev Urol. 2010;7(8):430–41 [Epub 2010 Jul 20].PubMedCrossRefGoogle Scholar
  11. 11.
    Medina-Bombardó D, Jover-Palmer A. Does clinical examination aid in the diagnosis of urinary tract infections in women? A systematic review and meta-analysis. BMC Fam Pract. 2011;12:111.PubMedCrossRefGoogle Scholar
  12. 12.
    Little P, Turner S, Rumsby K, et al. Validating the prediction of lower urinary tract infection in primary care: sensitivity and specificity of urinary dipsticks and clinical scores in women. Br J Gen Pract. 2010;60(576):495–500.PubMedCrossRefGoogle Scholar
  13. 13.
    Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34(5):407–13 [Epub 2009 Jun 7].PubMedCrossRefGoogle Scholar
  14. 14.
  15. 15.
    Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Guay DR. Cranberry and urinary tract infections. Drugs. 2009;69(7):775–807.PubMedCrossRefGoogle Scholar
  17. 17.
    Beerepoot MA, ter Riet G, Nys S, et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med. 2011;171(14):1270–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2008;(1):CD001321.Google Scholar
  19. 19.
    Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002;9(3):1558–62.PubMedGoogle Scholar
  20. 20.
    Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52(10):1212–7 [Epub 2011 Apr 14].PubMedCrossRefGoogle Scholar
  21. 21.
    Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101–14.PubMedCrossRefGoogle Scholar
  22. 22.
    Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Prevention of Catheter-Associated Urinary Tract Infections. 2009. Available for free download at Last Accessed 17 Feb 2012.
  23. 23.
    Trautner BW. Management of catheter-associated urinary tract infection. Curr Opin Infect Dis. 2010;23(1):76–82.PubMedCrossRefGoogle Scholar
  24. 24.
    Loeb M, Bentley DW, Bradley S, et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol. 2001;22(2):120–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Loeb M, Brazil K, Lohfeld L, et al. Effect of a multifaceted intervention on number of antimicrobial ­prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ. 2005;331(7518):669.PubMedCrossRefGoogle Scholar
  26. 26.
    Newman DK, Willson MM. Review of intermittent catheterization and current best practices. Urol Nurs. 2011;31(1):12–28, 48 [quiz 29].PubMedGoogle Scholar
  27. 27.
    Chartier-Kastler E, Denys P. Intermittent catheterization with hydrophilic catheters as a treatment of chronic neurogenic urinary retention. Neurourol Urodyn. 2011;30(1):21–31. doi: 10.1002/nau.20929 [Epub 2010 Oct 6].PubMedCrossRefGoogle Scholar
  28. 28.
    Getliffe K, Fader M, Allen C, Pinar K, Moore KN. Current evidence on intermittent catheterization: sterile single-use catheters or clean reused catheters and the incidence of UTI. J Wound Ostomy Continence Nurs. 2007;34(3):289–96.PubMedCrossRefGoogle Scholar
  29. 29.
    Bakke A, Malt UF. Psychological predictors of symptoms of urinary tract infection and bacteriuria in patients treated with clean intermittent catheterization: a prospective 7-year study. Eur Urol. 1998;34(1):30–6.PubMedCrossRefGoogle Scholar
  30. 30.
    van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. Int J Antimicrob Agents. 2010;36(6):485–90 [Epub 2010 Jun 26].PubMedCrossRefGoogle Scholar
  31. 31.
    Rees E. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol. 1980;138(7 Pt 2):1042–7.PubMedGoogle Scholar
  32. 32.
    Simms I, Stephenson JM. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? Sex Transm Infect. 2000;76(2):80–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Black CM, Marrazzo J, Johnson RE, et al. Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved ­reference standard. J Clin Microbiol. 2002;40(10):3757–63.PubMedCrossRefGoogle Scholar
  34. 34.
    Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, Pederson BS. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol. 2002;51(12):1021–31.PubMedGoogle Scholar
  35. 35.
    Shaw K, Coleman D, O’Sullivan M, Stephens N. Public health policies and management strategies for genital Chlamydia trachomatis infection. Risk Manag Healthc Policy. 2011;4:57–65.PubMedCrossRefGoogle Scholar
  36. 36.
    Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections – Morbidity and Mortality Weekly Report, August 10, 2012, 61(31);590–594 (
  37. 37.
    Bachmann LH, Hobbs MM, Seña AC, et al. Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis. 2011;53 Suppl 3:S160–72.PubMedCrossRefGoogle Scholar
  38. 38.
    Cotch MF, Pastorek 2nd JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997;24(6):353–60.PubMedCrossRefGoogle Scholar
  39. 39.
    Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet. 1998;351(9097):213–4.PubMedCrossRefGoogle Scholar
  40. 40.
    Potts JM, Ward MA, Rackley RR. Association of chronic urinary symptoms in women and Ureaplasma urealyticum. Urology. 2000;55:486–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Ventolini G, Lee M. Clinical antibiotic response of mycoplasma and ureaplasma in patients with symptomatic recurrent vulvovaginal colonization. J Reprod Med. 2011;56(3–4):138–41.PubMedGoogle Scholar
  42. 42.
    Mohan R, Mach KE, Bercovici M, Pan Y, Dhulipala L, Wong PK, Liao JC. Clinical validation of integrated nucleic acid and protein detection on an electrochemical biosensor array for urinary tract infection diagnosis. PLoS One. 2011;6(10):e26846.PubMedCrossRefGoogle Scholar
  43. 43.
    Chen CH, Lu Y, Sin ML, et al. Antimicrobial susceptibility testing using high surface-to-volume ratio microchannels. Anal Chem. 2010;82(3):1012–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Darouiche RO, Green BG, Donovan WH, et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011;78(2):341–6.PubMedCrossRefGoogle Scholar
  45. 45.
    Cruz F, Dambros M, Naber KG, Bauer HW, Cozma G. Recurrent urinary tract infections: Uro-Vaxom, a new alternative. Eur Urol Suppl. 2009;8(9):762–8.CrossRefGoogle Scholar
  46. 46.
    Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2008;33(2):111–9 [Epub 2008 Oct 28].PubMedCrossRefGoogle Scholar
  47. 47.
    Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol. 2007;177(4):1349–53 [quiz 1591].PubMedCrossRefGoogle Scholar
  48. 48.
    Alteri CJ, Hagan EC, Sivick KE, Smith SN, Mobley HL. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 2009;5(9):e1000586 [Epub 2009 Sep 18].PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of UrologyStanford UniversityStanfordUSA
  2. 2.Men’s Health ConsultantPalo AltoUSA

Personalised recommendations